NASDAQ:BSLK Bolt Projects 11/12/2025 Earnings Report $0.06 -0.02 (-20.46%) As of 02:35 PM Eastern ProfileEarnings HistoryForecast Bolt Projects EPS ResultsActual EPS-$2.70Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABolt Projects Revenue ResultsActual Revenue$0.37 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABolt Projects Announcement DetailsQuarterDate11/12/2025TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Bolt Projects Earnings HeadlinesBolt Projects Holdings Announces Delisting From Nasdaq and SEC DeregistrationFebruary 19, 2026 | businesswire.comBolt Projects sees FY25 revenue $4.5MDecember 30, 2025 | msn.comNNVC FDA = New Momentum Wave!NanoViricides (NYSE: NNVC) just received FDA Orphan Drug Designation for NV-387, its antiviral candidate targeting measles - a disease with no approved antiviral treatment and rising global case counts. Beyond measles, NV-387 is designed as a broad-spectrum platform targeting RSV, influenza, coronaviruses, and Mpox, giving NNVC exposure to multiple large markets as Phase II trials advance. The designation unlocks faster development timelines, financial incentives, and potential market exclusivity.May 12 at 1:00 AM | Equiscreen (Ad)Bolt Projects raises FY26 revenue view to $11M from $9MDecember 29, 2025 | msn.comBolt Projects Holdings Announces Preliminary Fiscal 2025 Results And Updates Fiscal 2026 GuidanceDecember 29, 2025 | businesswire.comBolt Projects Holdings Reports Q3 2025 Financial ResultsNovember 12, 2025 | businesswire.comSee More Bolt Projects Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Bolt Projects? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Bolt Projects and other key companies, straight to your email. Email Address About Bolt ProjectsBolt Projects (NASDAQ:BSLK) operates as a material solutions company. The company offers B-SILK PROTEIN, a biodegradable ingredient for the beauty and personal care industry. Its products also include MYLO, a mycelium-based leather material; and MICROSILK, a silk fiber. The company is based in San Francisco, California.View Bolt Projects ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Hims & Hers Stock Plunges After Q1 Miss: Is the GLP-1 Pivot Enough to Fuel a Recovery?On Holdings Sets Up for Marathon Rally: New Highs Are ComingShake Shack Stock Gets Shaken After Earnings MissRocket Lab Just Hit a New All-Time High—Time to Buy or Let It Breathe?Axon Surged After Earnings and Is Still Down Over 50% From HighsMP Materials Is Quietly Building a Rare Earth PowerhouseAST SpaceMobile Plummets on Galactic Q1 Miss: Can Vertical Integration Save the SpaceX Rival? Upcoming Earnings Cisco Systems (5/13/2026)Alibaba Group (5/13/2026)Manulife Financial (5/13/2026)Sumitomo Mitsui Financial Group (5/13/2026)Takeda Pharmaceutical (5/13/2026)Applied Materials (5/14/2026)Brookfield (5/14/2026)National Grid Transco (5/14/2026)NU (5/14/2026)Mizuho Financial Group (5/15/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
